Relationship Between Average Glucose Levels and HbA1c Differs Across Racial Groups: A Substudy of the GRADE Randomized Trial
- PMID: 39312277
- PMCID: PMC11655407
- DOI: 10.2337/dc24-1362
Relationship Between Average Glucose Levels and HbA1c Differs Across Racial Groups: A Substudy of the GRADE Randomized Trial
Abstract
Objective: To determine whether the relationship between average glucose (AG) levels and hemoglobin A1c (HbA1c) differs across racial/ethnic groups.
Research design and methods: We performed a prospective substudy of GRADE, a comparative effectiveness randomized trial conducted in 36 centers in the U.S. A total of 1,454 of the 5,047 participants in the GRADE cohort, including 534 non-Hispanic White (NHW), 389 non-Hispanic Black (NHB), and 327 Hispanic White patients and 204 patients of other racial/ethnic backgrounds, were included in the substudy. Continuous glucose monitoring (CGM) performed for 10 days was used to calculate AG10. Immediately after CGM, HbA1c and glycated albumin were measured. Fasting plasma glucose (FPG) and glucose area under the curve (AUC) were derived from a 75-g oral glucose tolerance test.
Results: The relationship between AG10 and HbA1c was significantly different for NHB compared with NHW patients and those of other racial/ethnic groups. HbA1c levels were 0.2-0.6 percentage points higher in NHB than in NHW patients for AG10 levels from 100 to 250 mg/dL. For an HbA1c of 7%, AG10 was 11 mg/dL higher for NHW than for NHB patients. Similar findings were observed across races for relationships of FPG and AUC with HbA1c and for glucose measurements with glycated albumin levels. Differences in the relationship between AG10 and HbA1c across racial groups remained after adjustments for any demographic or other differences between racial/ethnic subgroups.
Conclusions: The relationship between several measures of glucose with HbA1c and glycated albumin consistently differed across races. These findings should be considered in setting treatment goals and diagnostic levels.
© 2024 by the American Diabetes Association.
Conflict of interest statement
References
-
- Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A.. Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N Engl J Med 1976;295:417–420 - PubMed
-
- Nathan DM, Singer DE, Hurxthal K, Goodson JD.. The clinical information value of the glycosylated hemoglobin assay. N Engl J Med 1984;310:341–346 - PubMed
-
- Svendsen PA, Lauritzen T, Søegaard U, Nerup J.. Glycosylated haemoglobin and steady-state mean blood glucose concentration in type 1 (insulin-dependent) diabetes. Diabetologia 1982;23:403–405 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- UL1 TR000445/TR/NCATS NIH HHS/United States
- U01DK098246/DK/NIDDK NIH HHS/United States
- HL/NHLBI NIH HHS/United States
- UL1 TR002529/TR/NCATS NIH HHS/United States
- UL1 TR000439/TR/NCATS NIH HHS/United States
- P30 DK020541/DK/NIDDK NIH HHS/United States
- UL1 TR002378/TR/NCATS NIH HHS/United States
- UL1 TR001425/TR/NCATS NIH HHS/United States
- P30 DK020572/DK/NIDDK NIH HHS/United States
- UL1 TR002243/TR/NCATS NIH HHS/United States
- UL1 TR002345/TR/NCATS NIH HHS/United States
- UL1 TR002548/TR/NCATS NIH HHS/United States
- U34 DK088043/DK/NIDDK NIH HHS/United States
- UL1 TR002537/TR/NCATS NIH HHS/United States
- P30 DK092926/DK/NIDDK NIH HHS/United States
- American Diabetes Association
- UL1 TR002535/TR/NCATS NIH HHS/United States
- P30 DK072476/DK/NIDDK NIH HHS/United States
- P30 DK079626/DK/NIDDK NIH HHS/United States
- UL1 TR001409/TR/NCATS NIH HHS/United States
- U01 DK098246/DK/NIDDK NIH HHS/United States
- UL1 TR001449/TR/NCATS NIH HHS/United States
- UL1 TR002489/TR/NCATS NIH HHS/United States
- U54 GM104940/GM/NIGMS NIH HHS/United States
- UL1 TR001108/TR/NCATS NIH HHS/United States
- P30 DK017047/DK/NIDDK NIH HHS/United States
- CC/CDC HHS/United States
LinkOut - more resources
Full Text Sources
Medical